CombiGene and Cobra Biologics sign agreement to secure GMP production of plasmids
The agreement is part of preparations for GMP production of material for the first clinical study of CG01
The agreement is part of preparations for GMP production of material for the first clinical study of CG01
Join us on Thursday, September 24, to learn about the key factors that play a role in the ability of low-field NMR to analyze polymer systems
Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit
This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility
The distance sensors caters for measurement applications including hygiene management, measurement for social distancing and remote operations
Quick start electronic lab notebook helps start-ups capture experimental data, collaborate with ease and secure their IP from day one
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
Join us on Monday, September 21, to learn about assay development for high-throughput screening
New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021
Join us to learn about the latest methods for equines anti-doping analysis and the importance of liquid chromatography
Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers
Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development